We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

9533:TSETOHO GAS Co., Ltd. Analysis

Data as of 2026-05-26 - not real-time

¥1,284.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Toho Gas is trading just above its short‑term moving average while the mid‑term average sits slightly higher, leaving the price in a neutral technical zone. The relative strength index sits in the mid‑fifties, indicating neither overbought nor oversold conditions, and the MACD histogram remains positive, suggesting modest bullish momentum despite a declining volume trend. Volatility over the past month is elevated, yet the beta is essentially flat, meaning the stock moves largely independent of broader market swings. The dividend yield is modest and the payout ratio is comfortably low, supporting the view that dividend payments are sustainable.
Fundamentally, the company posts low return on equity and modest profit margins, while its debt‑to‑equity ratio is high for a utility, flagging balance‑sheet pressure. The price‑earnings multiple is below the sector average, offering some relative cheapness, but the discounted cash‑flow estimate is dramatically lower than the current market price, pointing to a substantial overvaluation. Given the mix of neutral technicals, high volatility, strong dividend sustainability, and weak growth fundamentals, the stock is best approached with caution and a bias toward holding rather than adding new exposure.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • neutral technical stance with modest bullish MACD
  • declining volume and elevated short‑term volatility
  • dividend sustainability offsets valuation concerns

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • persistent high debt level limiting earnings growth
  • price‑earnings ratio remains below industry average
  • DCF valuation indicates significant overpricing

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • weak return on equity and thin profit margins
  • substantially overvalued relative to intrinsic cash‑flow estimate
  • high leverage could impair future dividend capacity

Key Metrics & Analysis

Financial Health

Revenue Growth-5.00%
Profit Margin4.83%
P/E Ratio15.3
ROE6.79%
ROA2.53%
Debt/Equity32.13
P/B Ratio1.0
Op. Cash Flow¥65.6B
Free Cash Flow¥9.7B
Industry P/E22.0

Technical Analysis

TrendNeutral
RSI53.1
Support¥1,163.50
Resistance¥1,323.50
MA 20¥1,256.38
MA 50¥1,267.69
MA 200¥1,210.58
MACDBullish
VolumeDecreasing
Fear & Greed Index91.64

Valuation

Fair Value¥44.37
Target Price¥977.50
Upside/Downside-23.87%
GradeOvervalued
TypeValue
Dividend Yield1.76%

Risk Assessment

Beta0.07
Volatility30.17%
Sector RiskLow
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.